TXG — 10X Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for 10X Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	424	664	587	430	389
Net Total Accounts Receivable
Net Total Receivables	33.4	51.2	85.3	104	115
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	481	774	748	635	596
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	48.8	120	230	359	345
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	606	929	1,019	1,029	965
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	63	118	110	131	127
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	186	190	201	223	224
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	420	739	818	806	741
Total Liabilities & Shareholders' Equity	606	929	1,019	1,029	965
Total Common Shares Outstanding